Page 257 - IJB-9-1
P. 257

International Journal of Bioprinting                         3D printing of smart constructs for precise medicine


            degradation, and color, in response to the given signals. In   to reflect the condition of the lesions. Despite the absence
            this review, we provide an overview of the classifications   of multifunctional stimuli-responsive biomaterials, the
            and divisions of 3D printing or bioprinting techniques,   integration of available candidates and corresponding types
            biomaterials or bioinks, and commonly used stimuli-  of stimuli may be an optional approach to engineering
            responsive biomaterials, followed by a summary of recent   versatile smart constructs.
            biomedical applications of 3D-printed or -bioprinted smart   Third, numerous problems await when translating
            constructs in regenerative medicine, drug delivery, and   3D printing and bioprinting from laboratory to
            pathophysiology monitoring. Although these achievements   industrial settings. Although the automated fabrication
            have resulted in the dawn of smart constructs, several
            critical challenges in using this innovative technology   method is highly reproducible, large-scale production
            remain.                                            remains challenging. Considering medical and clinical
                                                               applications, a standardized production process, including
              First, the limited number of available intelligent   material preparation, fabrication, and packaging, should
            biomaterials is a major challenge to produce smart   be established in accordance with good manufacturing
            constructs. Despite the abundant emergence of stimuli-  practices to avoid unexpected contaminations. Moreover,
            responsive materials, most of them are not eligible   for products containing cells and fragile biological or
            candidates for biomedical applications because they do   chemical components, their viability and stability during
            not fulfill two important criteria, biocompatibility and 3D   storage and transportation should be considered.
            printability. A few pioneering studies have demonstrated
            that properties such as adhesion, migration, and     Finally, although the existing literature has demonstrated
            contraction can be utilized to actuate 3D-bioprinted   the potential of smart bioconstructs and biomedical
            structures,  showing  that  it  is  possible  to  create   devices, most of them are proof-of-concept studies that
            living smart constructs. When producing constructs   are still in their infancy. The most of the reviewed reports
            using cell-laden bioinks, 3D bioprinting techniques   describe works that are still in the fundamental research
            have additional requirements for the properties of   phase, and no prototypes have been developed for clinical
            biomaterials, including cell-friendliness, rheology, and   trials. Hence, FDA-approved smart constructs are currently
            crosslinking performance. In addition, when executing   not available. Advancing the smart constructs into clinical
            specific functions, such as shape transformation,   scenarios  requires  in vitro  and  in  vivo  experiments  to
            biomaterials should exhibit reasonable mechanical   validate their safety and efficacy.
            strength. Therefore, an increased focus should be placed   In conclusion, 3D printing of smart constructs is an
            on developing novel, applicable intelligent biomaterials   emerging research subject that has proven its extraordinary
            to advance smart constructs.                       potential for the next generation of bioproducts and
              Second, the smart constructs summarized in this review   biomedical devices and as a future direction of tissue
            are categorized into three groups: Tissue regeneration,   engineering. Overcoming the current challenges requires
            drug delivery, and monitoring. However, to alleviate the   multidisciplinary collaborations to enrich the pool of
            suffering of patients and clinical burdens, the constructs are   smart biomaterials, clarify clinical demands, and complete
            expected to be multifunctional and should be able to serve   the pre-clinical evaluations.
            both therapeutic and diagnostic purposes when stimuli are
            supplied on demand. For instance, conventional vascular   Acknowledgments
            stents are usually designed to be delivered using a catheter   None.
            to mechanically expand the stenotic blood vessels. Several
            studies have developed 3D-printed vascular stents using   Funding
            heat-  and magnetically-sensitive biopolymers. Designs
            utilizing shape-memory transformations or magnetic   This study was funded by the Beijing Institute of Technology
            field-triggered navigation have significantly eased and   Research Fund Program for Young Scholars (XSQD-
            improved the precision of the deployment process.   202123003) and the Fundamental Research Funds for the
            However, the ability to provide radial force to support   Central Universities (No. LY2022-22). This research was
            and regain the diameter of the narrowed vessels is just one   also supported by a National Research Foundation of Korea
            of the many properties required for vascular stents. An   (NRF) grant funded by the Korean government (MSIT)
            ideal smart stent should encompass other critical features,   (No.2022R1C1C1004803 and 2022R1A5A2027161).
            such as the programmable release of drugs for recovering   Conflict of interest
            atherosclerotic plaques, controllable degradation to prevent
            the generation of hyperplastic tissues, and trackable signals   The authors declare they have no competing interests.


            Volume 9 Issue 1 (2023)                        249                      https://doi.org/10.18063/ijb.v9i1.638
   252   253   254   255   256   257   258   259   260   261   262